サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1559556

肺がん手術の世界市場

Lung Cancer Surgery

出版日
ページ情報
英文 279 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
肺がん手術の世界市場
出版日: 2024年09月24日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 279 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

肺がん手術の世界市場は2030年までに83億米ドルに到達

2023年に62億米ドルと推定される肺がん手術の世界市場は、分析期間2023-2030年にCAGR 4.2％で成長し、2030年には83億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである胸腔切開法は、CAGR 4.1％を記録し、分析期間終了までに58億米ドルに達すると予測されます。最小侵襲手術セグメントの成長率は、分析期間でCAGR 4.6％と推定されます。

米国市場は17億米ドルと推定、中国はCAGR6.5％で成長予測

米国の肺がん手術市場は2023年に17億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに18億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは6.5%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.7%と3.2%と予測されています。欧州では、ドイツがCAGR 3.3%で成長すると予測されています。

世界の肺がん手術市場- 主要動向と促進要因のまとめ

なぜ肺がん手術は今日のがん治療において重要な要素なのか？

肺がんは依然として世界で最も蔓延し、致命的ながんの一つであり、この病気との闘いにおいて手術のような効果的な治療方法が極めて重要となっています。肺がんの手術では、腫瘍とがん細胞が広がっている可能性のある周囲の肺組織を切除します。この方法は一般的に、腫瘍が限局していて手術が可能な肺がん、特に非小細胞肺がん（NSCLC）の初期段階で最も効果的です。ビデオ支援胸部手術（VATS）やロボット支援手術などの低侵襲手術を含む手術手技の進歩により、患者の転帰は著しく改善されています。これらの手技は、従来の開胸手術に比べ、手術外傷や回復時間を減らし、合併症のリスクを低減し、術後の生活の質を改善することができます。発見方法が改善され、より多くの肺がんが手術可能な段階で診断されるようになるにつれ、治療レジメンにおける手術の役割は拡大し続けています。

技術の進歩は肺がん手術をどのように変えているのか？

肺がん手術を取り巻く環境は、より正確で侵襲の少ない手術を可能にする技術の進歩によって一変しました。ロボット手術のような技術革新は、外科医に高い器用さとコントロールを提供し、健康な組織を温存しながら複雑な解剖を行い、腫瘍を高い精度で取り除くことを可能にします。さらに、リアルタイムCTスキャンや蛍光画像診断などの術中画像診断技術により、腫瘍の位置や切除断端の評価の精度が向上し、最初の手術でより多くのがん組織が確実に切除されるようになった。これらの進歩は外科的介入の成功率を高めるだけでなく、患者への身体的影響を最小限に抑え、回復時間の短縮や術後の不快感の軽減につながります。

早期発見と個別化治療は、肺がん手術の転帰にどのような影響を与えるか？

早期発見と個別化治療のアプローチは、肺がん手術の転帰に大きな影響を与えています。高リスク者に対する低線量CTスクリーニングの開発により、肺がんの早期診断が可能となり、外科的切除が可能で治癒の可能性が高い段階で診断されることが多くなった。また、腫瘍の遺伝子プロファイリングを行い、腫瘍の特徴を理解する個別化医療は、どの患者が手術の良い候補であるか、化学療法や標的治療などの追加治療にどのように反応するかを決定する上で飛躍的な進歩を遂げました。このようなオーダーメイドのアプローチは、手術の有効性を最大化し、不必要な治療を最小化する治療計画の立案に役立ちます。

肺がん手術市場の成長は複数の要因によってもたらされる

肺がん手術市場の成長は、技術的進歩、検出方法の改善、個別化医療の重視の高まりなど、いくつかの要因によって牽引されています。低侵襲手術やロボット支援手術などの手術手技における技術革新は、手術可能な症例の幅を広げ、患者の転帰を改善し、多くの患者にとって手術がより現実的な選択肢となっています。また、検診プログラムの充実も、外科的介入が最も有益となる早期がんの発見数を増加させるという重要な役割を果たしています。さらに、肺がんの遺伝的基盤の理解が進むにつれて、個別化された外科治療が普及し、より的を絞った効果的な介入が可能となっています。このような進展は、肺がんのリスクと予防に対する意識の高まりと相まって、肺がん治療における外科的ソリューションに対する需要を牽引し続けており、ダイナミックで進化するマーケットプレースを反映しています。

調査対象企業の例（合計 111注目）

  • Abbott Molecular, Inc.
  • AbbVie, Inc.
  • Accuray, Inc.
  • Ackermann Instrumente GmbH
  • AngioDynamics, Inc.
  • Baxter International, Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Daiichi Sankyo Co., Ltd.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP13120

Global Lung Cancer Surgery Market to Reach US$8.3 Billion by 2030

The global market for Lung Cancer Surgery estimated at US$6.2 Billion in the year 2023, is expected to reach US$8.3 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2023-2030. Thoracotomy Procedure, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$5.8 Billion by the end of the analysis period. Growth in the Minimally Invasive Surgery segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.7 Billion While China is Forecast to Grow at 6.5% CAGR

The Lung Cancer Surgery market in the U.S. is estimated at US$1.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.8 Billion by the year 2030 trailing a CAGR of 6.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Global Lung Cancer Surgery Market - Key Trends & Drivers Summarized

Why Is Lung Cancer Surgery a Critical Component of Cancer Treatment Today?

Lung cancer remains one of the most prevalent and deadly cancers worldwide, making effective treatment modalities like surgery crucial in the fight against this disease. Surgery for lung cancer involves the removal of the tumor and surrounding lung tissue where cancer cells may have spread. This approach is generally most effective in the early stages of lung cancer, specifically non-small cell lung cancer (NSCLC), where the tumor is localized and operable. Advances in surgical techniques, including minimally invasive procedures such as video-assisted thoracic surgery (VATS) and robot-assisted surgery, have significantly improved outcomes for patients. These techniques reduce surgical trauma and recovery time, decrease the risk of complications, and can improve the quality of life post-surgery compared to traditional open surgery. As detection methods improve and more lung cancers are diagnosed at an operable stage, the role of surgery in treatment regimens continues to expand.

How Are Technological Advances Transforming Lung Cancer Surgery?

The landscape of lung cancer surgery has been transformed by technological advancements that allow for more precise and less invasive procedures. Innovations such as robotic surgery provide surgeons with enhanced dexterity and control, enabling them to perform complex dissections and remove tumors with high precision while preserving healthy tissue. Furthermore, intraoperative imaging technologies like real-time CT scans and fluorescence imaging have improved the accuracy of tumor localization and the assessment of resection margins, ensuring that more of the cancerous tissue is removed during the initial surgery. These advancements not only increase the success rate of surgical interventions but also minimize the physical impact on patients, leading to faster recovery times and less postoperative discomfort.

What Impact Do Early Detection and Personalized Treatment Have on Lung Cancer Surgery Outcomes?

Early detection and personalized treatment approaches are significantly influencing outcomes in lung cancer surgery. The development of low-dose CT screening for high-risk individuals has led to earlier diagnosis of lung cancer, often at a stage when surgical resection is possible and more likely to be curative. Personalized medicine, which involves genetic profiling of tumors to understand their unique characteristics, has also made strides in determining which patients are good candidates for surgery and how they might best respond to additional treatments such as chemotherapy or targeted therapy. This tailored approach helps in strategizing treatment plans that maximize the efficacy of surgery and minimize unnecessary treatments, thereby improving overall patient survival and quality of life.

Growth in the Lung Cancer Surgery Market Is Driven by Several Factors

The growth in the lung cancer surgery market is driven by several factors, encompassing technological advancements, improved detection methods, and an increased emphasis on personalized medicine. Technological innovations in surgical techniques, including minimally invasive and robotic-assisted surgeries, have broadened the range of operable cases and improved patient outcomes, making surgery a more viable option for many patients. Enhanced screening programs have also played a critical role, as they increase the number of early-stage cancers identified, where surgical intervention can be most beneficial. Additionally, as understanding of the genetic basis of lung cancer improves, personalized surgical treatments are becoming more prevalent, allowing for more targeted and effective interventions. These developments, combined with a growing awareness of lung cancer risks and prevention, continue to drive the demand for surgical solutions in the treatment of lung cancer, reflecting a dynamic and evolving marketplace.

Select Competitors (Total 111 Featured) -

  • Abbott Molecular, Inc.
  • AbbVie, Inc.
  • Accuray, Inc.
  • Ackermann Instrumente GmbH
  • AngioDynamics, Inc.
  • Baxter International, Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Daiichi Sankyo Co., Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Lung Cancer Surgery - Global Key Competitors Percentage Market Share in 2024 (E)
    • Global Economic Update
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Lung Cancer Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Lung Cancer Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Lung Cancer Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Thoracotomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Thoracotomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Thoracotomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Surgical Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Surgical Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Surgical Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Monitoring & Visualizing Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Monitoring & Visualizing Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Monitoring & Visualizing Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Lung Cancer Surgery Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Minimally Invasive Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Minimally Invasive Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Minimally Invasive Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Endosurgical Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Endosurgical Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Endosurgical Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • JAPAN
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • CHINA
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • EUROPE
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Lung Cancer Surgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Lung Cancer Surgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Lung Cancer Surgery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • FRANCE
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • GERMANY
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Lung Cancer Surgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Lung Cancer Surgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Lung Cancer Surgery by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • INDIA
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Lung Cancer Surgery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Lung Cancer Surgery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Lung Cancer Surgery by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Lung Cancer Surgery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Lung Cancer Surgery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Lung Cancer Surgery by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • AFRICA
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030

IV. COMPETITION